awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34726309-38AF4145-C47C-4CC4-AC14-C9A73D978852
Q34726309-38AF4145-C47C-4CC4-AC14-C9A73D978852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34726309-38AF4145-C47C-4CC4-AC14-C9A73D978852
The clinical development program of lixisenatide: a once-daily glucagon-like Peptide-1 receptor agonist.
P2860
Q34726309-38AF4145-C47C-4CC4-AC14-C9A73D978852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34726309-38AF4145-C47C-4CC4-AC14-C9A73D978852
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f3f49f3b59cf9ac0b2556a02f078389ab85b86f6
P2860
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).